Providing Market Intelligence for 40 Years

In The News

Connected health: An emerging driver to deliver on healthcare's Triple Aim

Access to patient-generated data from digital-health devices, however, provides verifiable, real-time updates that can help physicians better manage patients and lead to improved patient outcomes. When receiving data in real time, clinicians can analyze patient progress and intervene before a negative health event; this can also be automated with analytic and business intelligence software. In addition, when patient-generated data is combined with electronic medical record (EMR) data, clinicians then have a holistic view into patient activities within and outside of the provider setting. In fact, research recently released from Parks Associates confirms that healthcare professionals see EMR and device-generated data as the two most valuable data sources for the healthcare industry. Such data supports the delivery of personalized medicine and value-based care.

From the article "Connected health: An emerging driver to deliver on healthcare's Triple Aim" by Ryan Beckland.

Previously In The News

Pay-TV Providers Are Signing Up a Lot of Netflix Subscribers

As of last month, around one out of every five pay-TV households subscribe to an online video service through their pay-TV providers, according to a survey from Parks Associates. That's good news for...

Roku Is Taking the Right Steps

Last August, market analysts at Parks Associates found that more than any other streaming media device -- including those from Amazon, Apple, and Google -- Roku was the leading brand and had increased...

Netflix Is Killing It—Big Time—After Pouring Cash Into Original Shows

“There seemed to be an attitude around the industry that after House of Cards and Orange is the New Black, there was no way Netflix could catch lightning in a bottle again,” says Glenn Hower, a senior...

The Simple Reason Why I Won't Buy Roku Inc.

Roku (NASDAQ:ROKU) went public on Sep. 28, its stock surging nearly 70% from its IPO price of $14 per share. The stock hit almost $30 the following day, but subsequently pulled back to the low $20s....